COL11A1 and cancer: This result is consistent with our prior in situ hybridization findings that only a small number of patients (∼20%) expressed COL11A1 in cancer-associated fibroblasts (CAFs) in primary ovarian HGSC, while the majority of patient-matched metastases expressed COL11A1 in CAFs (Cheon et al., 2014).